Stifel Financial
CUE icon

Stifel Financial’s Cue Biopharma CUE Stock Holding History

Stifel Financial’s Portfolio CUE Stock Details CUE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$259K Sell
8,218
-1
-0% -$23 ﹤0.01% 3367
2026
Q1 		$56.7K Hold
8,219
– – ﹤0.01% 3570
2025
Q4 		$75.3K Buy
8,219
+1,667
+25% +$30.6K ﹤0.01% 3508
2025
Q3 		$141K Hold
6,552
– – ﹤0.01% 3405
2025
Q2 		$134K Sell
6,552
-234
-3% -$4.99K ﹤0.01% 3328
2025
Q1 		$185K Sell
6,786
-259
-4% -$9.62K ﹤0.01% 3205
2024
Q4 		$230K Buy
7,045
+571
+9% +$21.5K ﹤0.01% 3101
2024
Q3 		$147K Buy
6,474
+8
+0.1% +$173 ﹤0.01% 3190
2024
Q2 		$241K Buy
6,466
+46
+0.7% +$2.27K ﹤0.01% 3022
2024
Q1 		$364K Sell
6,420
-46
-0.7% -$3.25K ﹤0.01% 2794
2023
Q4 		$512K Buy
6,466
+1,559
+32% +$111K ﹤0.01% 2544
2023
Q3 		$339K Sell
4,907
-4
-0.1% -$391 ﹤0.01% 2721
2023
Q2 		$538K Buy
4,911
+29
+0.6% +$3.41K ﹤0.01% 2476
2023
Q1 		$523K Buy
4,882
+537
+12% +$51.2K ﹤0.01% 2488
2022
Q4 		$372K Buy
4,345
+2,123
+96% +$194K ﹤0.01% 2638
2022
Q3 		$148K Hold
2,222
– – ﹤0.01% 3029
2022
Q2 		$165K Hold
2,222
– – ﹤0.01% 3059
2022
Q1 		$325K Hold
2,222
– – ﹤0.01% 2834
2021
Q4 		$754K Buy
2,222
+26
+1% +$10.1K ﹤0.01% 2324
2021
Q3 		$960K Hold
2,196
– – ﹤0.01% 2130
2021
Q2 		$768K Hold
2,196
– – ﹤0.01% 2293
2021
Q1 		$804K Hold
2,196
– – ﹤0.01% 2140
2020
Q4 		$824K Hold
2,196
– – ﹤0.01% 1986
2020
Q3 		$991K Hold
2,196
– – ﹤0.01% 1636
2020
Q2 		$1.61M Buy
2,196
+334
+18% +$242K ﹤0.01% 1270
2020
Q1 		$792K Hold
1,862
– – ﹤0.01% 1573
2019
Q4 		$887K Hold
1,862
– – ﹤0.01% 1913
2019
Q3 		$471K Hold
1,862
– – ﹤0.01% 2202
2019
Q2 		$502K Buy
+1,862
New +$463K ﹤0.01% 2204

Other funds holding CUE

BL
Bleichroeder LP New York $559M AUM 83.7% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
IC
Ikarian Capital Dallas, Texas $928M AUM 596.14% 1-Year Est. Return
TAM
TFG Asset Management Grand Cayman, Cayman Islands $635M AUM 28.07% 1-Year Est. Return
SC
Stempoint Capital New York $581M AUM 373.68% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $2.19B AUM 374.99% 1-Year Est. Return
LPC
Lion Point Capital New York $20.9M AUM 195.52% 1-Year Est. Return
SCM
Squadron Capital Management Westmont, Illinois $322M AUM

Stifel Financial's CUE Position: Q2 2026 in Review

Stifel Financial reduced its Cue Biopharma (CUE) stake by 0.01% in Q2 2026, selling an estimated $23 and leaving 8,218 shares worth $259K. The position accounts for ﹤0.01% of the portfolio, ranked #3367.

Stifel Financial first reported a position in CUE in Q2 2019 and has held it in 29 quarters since. The position peaked at $1.61M in Q2 2020. 49 funds tracked by Wall St. Rank hold CUE as of Q2 2026.

  • Stifel Financial held 8,218 shares of Cue Biopharma worth $259K as of Q2 2026.
  • Stifel Financial sold 1 Cue Biopharma share in Q2 2026, an estimated $23.
  • Cue Biopharma made up ﹤0.01% of Stifel Financial's portfolio in Q2 2026, its #3367 holding.
  • Stifel Financial first reported a position in Cue Biopharma in Q2 2019 and has held it in 29 quarters since.
  • Stifel Financial's Cue Biopharma position peaked at $1.61M in Q2 2020.
  • 49 funds tracked by Wall St. Rank held Cue Biopharma as of Q2 2026.

Based on Stifel Financial's 13F filing for Q2 2026, filed 12 Aug 2026.